Resultados globales: 9 registros encontrados en 0.01 segundos.
Artículos, Encontrados 9 registros
Artículos Encontrados 9 registros  
1.
9 p, 3.3 MB Renal function dynamics following co-administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes / de la Espriella, Rafael (Universitat de València) ; Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ; Morillas, Herminio (Hospital de Dénia-MarinaSalud) ; Bravo, Rafael (Hospital Costa del Sol) ; Vidal, Verónica (Hospital General de València) ; Núñez, Eduardo (Universitat de València) ; Santas, Enrique (Universitat de València) ; Miñana, Gema (Universitat de València) ; Sanchis, Juan (CIBER in Cardiovascular Diseases (CIBERCV)) ; Fácila, Lorenzo (Hospital General de València) ; Torres, Francisco (Hospital de Dénia-MarinaSalud) ; Górriz, Jose Luis (Universitat de València) ; Valle, Alfonso (Hospital de Dénia-MarinaSalud) ; Núñez, Julio (CIBER in Cardiovascular Diseases (CIBERCV))
The aim of this study was to evaluate the safety profile in terms of changes in renal function after co-treatment with sacubitril/valsartan and empagliflozin in patients with type 2 diabetes (T2D) and heart failure with reduced ejection fraction (HFrEF). [...]
2020 - 10.1002/ehf2.12965
ESC Heart Failure, Vol. 7 (september 2020) , p. 3792-3800  
2.
3 p, 226.3 KB Intrarenal venous flow in cardiorenal syndrome : a shining light into the darkness / de la Espriella-Juan, Rafael (CIBER in Cardiovascular Diseases (CIBERCV)) ; Núñez, Eduardo (CIBER in Cardiovascular Diseases (CIBERCV)) ; Miñana, Gema (CIBER in Cardiovascular Diseases (CIBERCV)) ; Sanchis, Juan (CIBER in Cardiovascular Diseases (CIBERCV)) ; Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ; González, Jessika (CIBER in Cardiovascular Diseases (CIBERCV)) ; Chorro, Javier (CIBER in Cardiovascular Diseases (CIBERCV)) ; Núñez, Julio (CIBER in Cardiovascular Diseases (CIBERCV))
The aim of this case report is to assess the potential role of intrarenal Doppler ultrasonography as a non-invasive method to evaluate intrarenal venous flow (IRVF) in acute heart failure (AHF) and concomitant renal dysfunction. [...]
2018 - 10.1002/ehf2.12362
ESC Heart Failure, Vol. 5 (october 2018) , p. 1173-1175  
3.
11 p, 2.0 MB Long-term LVEF trajectories in patients with type 2 diabetes and heart failure : diabetic cardiomyopathy may underlie functional decline / Julián, María Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Alonso, Núria (Universitat Autònoma de Barcelona. Departament de Medicina) ; Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gavidia-Bovadilla, Giovana (Hospital Clínic Universitari (València)) ; Ferrer, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; de Antonio Ferrer, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; López-Ayerbe, Jorge (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Domingo, Mar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santiago Vacas, Evelyn (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Zamora, Elisabet (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Codina, Pau (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Moliner, Pedro (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Núñez, Julio (Universitat de València. Department of Medicine) ; Santesmases, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Puig Domingo, Manuel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Left ventricular ejection fraction (LVEF) trajectories and functional recovery with current heart failure (HF) management is increasingly recognized. Type 2 diabetes mellitus (T2D) leads to a worse prognosis in HF patients. [...]
2020 - 10.1186/s12933-020-01011-w
Cardiovascular diabetology, Vol. 19 (march 2020)  
4.
8 p, 326.6 KB Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction / Santas, Enrique (Hospital Clínic Universitari (València)) ; de la Espriella, Rafael (Hospital Clínic Universitari (València)) ; Palau, Patricia (Hospital General de Castellón, Universitat Jaume I) ; Miñana, Gema (Hospital Clínic Universitari (València)) ; Amiguet, Martina (Hospital Clínic Universitari (València)) ; Sanchis, Juan (Hospital Clínic Universitari (València)) ; Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Chorro, Francisco Javier (Hospital Clínic Universitari (València)) ; Núñez Villota, Julio (Hospital Clínic Universitari (València)) ; Universitat Autònoma de Barcelona
Heart failure with mid-range ejection fraction (HFmrEF) has been proposed as a distinct HF phenotype, but whether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) or preserved EF (HFpEF) in terms of rehospitalization risks over time remains unclear. [...]
2020 - 10.1002/ehf2.12683
ESC Heart Failure, Vol. 7 (march 2020) , p. 1007-1014  
5.
8 p, 940.6 KB Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure : a pilot study / Revuelta-López, Elena (Institut Germans Trias i Pujol) ; Núñez, Julio (Hospital Clínic Universitari (València)) ; Gastelurrutia, Paloma (Institut Germans Trias i Pujol) ; Januzzi, James L. (Massachusetts General Hospital and Cardiometabolic Trials, Baim Institute for Clinical Research) ; Ibrahim, Nasrien E. (Massachusetts General Hospital and Cardiometabolic Trials, Baim Institute for Clinical Research) ; Emdin, Michele (Scuola Superiore Sant'Anna, Fondazione Toscana Gabriele Monasterio) ; VanKimmenade, Roland (Radboud University Medical Centre) ; Pascual-Figal, Domingo (Universidad de Murcia) ; Núñez, Eduardo (Hospital Clínic Universitari (València)) ; Gommans, Frank (Radboud University Medical Centre) ; Lupón, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ; Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina)
Sacubitril/valsartan is a first-in-class angiotensin receptor-neprilysin inhibitor developed for the treatment of heart failure with reduced ejection fraction. Its benefits are achieved through the inhibition of neprilysin (NEP) and the specific blockade of the angiotensin receptor AT1. [...]
2020 - 10.1002/ehf2.12607
ESC Heart Failure, Vol. 7 (february 2020) , p. 559-566  
6.
11 p, 407.0 KB Sodium-glucose cotransporter 2 inhibition : towards an indication to treat diabetic kidney disease / Górriz, Jose Luis (REDINREN) ; Navarro-González, Juan F (Instituto de Tecnologías Biomédicas, Universidad de La Laguna) ; Ortiz, Alberto (IIS-Fundación Jimenez Diaz UAM and School of Medicine) ; Vergara, Ander (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Nuñez, Julio (CIBER Cardiovascular) ; Jacobs-Cachá, Conxita (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martínez-Castelao, Alberto (Hospital Universitari de Bellvitge) ; Soler, María José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin-angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with overt DKD. [...]
2020 - 10.1093/ndt/gfz237
Nephrology Dialysis Transplantation, Vol. 35 (January 2020) , p. i13-i23  
7.
10 p, 559.2 KB Genetic etiology for alcohol-induced cardiac toxicity / Ware, James S. (Imperial College London. National Heart and Lung Institute) ; Amor-Salamanca, Almudena (Hospital Universitario Puerta de Hierro. Departamento de Cardiología) ; Tayal, Upasana (Imperial College London. National Heart and Lung Institute) ; Govind, Risha (Imperial College London. National Heart and Lung Institute) ; Serrano, Isabel (Hospital Universitari Joan XXIII de Tarragona) ; Salazar-Mendiguchía, Joel (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; García-Pinilla, Jose Manuel (Hospital Universitario Virgen de la Victoria. Departamento de Cardiología) ; Pascual-Figal, Domingo A. (Hospital Universitario Virgen de la Arrixaca. Departamento de Cardiología) ; Nuñez, Julio (INCLIVA (Valencia, Spain). Departamento de Cardiología) ; Guzzo-Merello, Gonzalo (Hospital Universitario Puerta de Hierro. Departamento de Cardiología) ; Gonzalez-Vioque, Emiliano (Hospital Universitario Puerta de Hierro. Departamento de Bioquímica) ; Bardají, Alfredo (Hospital Universitari Joan XXIII de Tarragona) ; Manito, Nicolas (Hospital Universitari de Bellvitge) ; López-Garrido, Miguel A. (Hospital Universitario Virgen de la Victoria. Departamento de Cardiología) ; Padron-Barthe, Laura (Hospital Universitario Puerta de Hierro. Departamento de Cardiología) ; Edwards, Elizabeth (Imperial College London. National Heart and Lung Institute) ; Whiffin, Nicola (Imperial College London. National Heart and Lung Institute) ; Walsh, Roddy (Imperial College London. National Heart and Lung Institute) ; Buchan, Rachel J. (Imperial College London. National Heart and Lung Institute) ; Midwinter, William (Imperial College London. National Heart and Lung Institute) ; Wilk, Alicja (Imperial College London. National Heart and Lung Institute) ; Prasad, Sanjay (Imperial College London. National Heart and Lung Institute) ; Pantazis, Antonis (Royal Brompton and Harefield. Cardiovascular Research Centre) ; Baski, John (Royal Brompton and Harefield. Cardiovascular Research Centre) ; O'Regan, Declan P. (Imperial College London. MRC London Institute of Medical Sciences) ; Alonso-Pulpón, Luis (Hospital Universitario Puerta de Hierro. Departamento de Cardiología) ; Cook, Stuart A. (Imperial College London. National Heart and Lung Institute) ; Lara-Pezzi, Enrique (Centro Nacional de Investigaciones Cardiovasculares (Madrid, Spain)) ; Barton, Paul J. (Imperial College London. National Heart and Lung Institute) ; Garcia-Pavia, Pablo (Universidad Francisco de Vitoria)
Alcoholic cardiomyopathy (ACM) is defined by a dilated and impaired left ventricle due to chronic excess alcohol consumption. It is largely unknown which factors determine cardiac toxicity on exposure to alcohol. [...]
2018 - 10.1016/j.jacc.2018.03.462
Journal of the American College of Cardiology, Vol. 71, issue 20 (May 2018) , p. 2293-2302  
8.
9 p, 933.2 KB Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction / Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Rueda, Ferran (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Oxvig, Claus (Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark) ; Oliveras, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Labata, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; de Diego, Oriol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ferrer, Marc (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Aranda-Nevado, M. Cruz (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Serra-Gregori, Judith (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Núñez, Julio (Departamento de Medicina, Universitat de València) ; García, Cosme (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
The aim of the present study was to evaluate the prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in patients with ST-segment elevation myocardial infarction (STEMI). Observational cohort study performed in 1085 consecutive STEMI patients treated with early reperfusion between February 2011 and August 2014. [...]
2018 - 10.1186/s12933-018-0710-3
Cardiovascular diabetology, Vol. 17 (april 2018)  
9.
8 p, 478.4 KB Multi-Biomarker Profiling and Recurrent Hospitalizations in Heart Failure / Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Department de Medicina) ; Núñez, Julio (Universitat de València) ; Núñez, Eduardo (Hospital Clínic Universitari (València)) ; Martínez, Jaume Barallat (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ferrer, Maria-Cruz Pastor (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; de Antonio, Marta (Universitat Autònoma de Barcelona. Department de Medicina) ; Zamora, Elisabet (Universitat Autònoma de Barcelona. Department de Medicina) ; Sanchis, Juan (Universitat de València) ; Rosés, Josep Lupón (Universitat Autònoma de Barcelona. Department de Medicina)
Despite advances in pharmacologic therapy and devices, patients with heart failure (HF) continue to have significant rehospitalization rates and risk prediction remains challenging. We sought to explore the value of a multi-biomarker panel [including NT-proBNP, high-sensitivity cardiac troponin T (hs-TnT), and ST2] on top of clinical assessment for long-term prediction of recurrent hospitalizations in HF. [...]
2016 - 10.3389/fcvm.2016.00037
Frontiers in Cardiovascular Medicine, Vol. 3 (october 2016)  

Vea también: autores con nombres similares
3 Nunez, J.
3 Nuñez, J.
2 Nuñez, Jorge
7 Nuñez, Jorge H.
1 Nuñez, Juan Carlos
5 Nuñez, Juan Felipe
3 Núñez, J.
1 Núñez, J.I.
1 Núñez, Jordi
2 Núñez, Jorge
7 Núñez, Jorge H.
1 Núñez, José I
4 Núñez, José I.
1 Núñez, Juan A.
1 Núñez, Juan L.
15 Núñez, Julio
15 Núñez, Julio
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.